Over 6.75 crore COVID vaccine doses administered in India so far

Share

President Joe Biden has vowed to provide enough shots to vaccinate all US adults by late May and recently set a new goal of administering 200 million injections within his first 100 days in office.

The cumulative number of COVID-19 vaccine doses administered in the country has crossed 6.75 crore with a total of 17,47,094 doses given on Thursday till 8 pm, the health ministry said as India opened up vaccination against the viral disease for all people aged above 45 from April 1.

"Various inputs have been received from different sources that in some of the COVID-19 vaccination centres (CVCs), some ineligible beneficiaries are being registered as HCWs and FLWs and are getting vaccinated in complete violation of the prescribed guidelines", Bhushan said. The vaccination of the Frontline Workers (FLWs) started on February 2. He added that there has been an increase of 24 per cent in the database for HCWs in the past few days.

Around one month has elapsed since these timelines and the country had started to vaccinate those above 60 years, the health official noted.

Announcement on possible new restrictions coming to Mississauga, Brampton and Ontario
The physicians noted that variants of concern have been quickly spreading across Ontario, which has impacted ICU capacity. He will be joined by Christine Elliott, Deputy Premier and Minister of Health, Dr.

Registrations of persons aged 45 years and above will continue to be permitted on CoWIN platform. Amid the sharp uptick in the Covid-19 cases in Ludhiana, the district administration on March 26, 2021, had launched a unique initiative "Vaccine at Doorsteps" to inoculate a larger population in a short period to break the transmission chain of virus.

Almost 4 million people in NY are fully vaccinated against Covid-19, according to Gov. Andrew Cuomo's office. "However, universal vaccination of already registered HCWs and FLWs should be ensured at the earliest".

"Both of these revisions positively impact the supply of Moderna COVID-19 Vaccine, which will help provide more vaccine doses to communities and allow shots to get into arms more quickly", Peter Marks, director of FDA's Center for Biologics Evaluation and Research, said.

Share